Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Central Nervous System Neoplasms 27Astrocytoma 15Oligodendroglioma 14Glioblastoma 14Gliosarcoma 12Glioma 11Brain Neoplasms 11Ependymoma 4Spinal Cord Neoplasms 3Neuroblastoma 3Somatostatinoma 2Neoplasm Metastasis 2Melanoma 2Medulloblastoma 2Lymphoma 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenoma, Islet Cell 2Sarcoma, Ewing 1Rhabdoid Tumor 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Optic Nerve Glioma 1Neurotoxicity Syndromes 1Neuroectodermal Tumors, Primitive 1Leukemia 1Insulinoma 1Glucagonoma 1Glioma, Subependymal 1Gastrointestinal Stromal Tumors 1Gastrinoma 1

Interventions

Paclitaxel 4Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Psychiatric Rehabilitation 2Mental Status and Dementia Tests 2Cisplatin 2Amifostine 2Vincristine 1Temozolomide 1Rituximab 1Procarbazine 1Methotrexate 1Memantine 1Magnetic Resonance Spectroscopy 1Diffusion Tensor Imaging 1Cytarabine 1Carboplatin 1Brachytherapy 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Neurotoxicity Syndromes × Temozolomide × Clear all
NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Eastern Cooperative Oncology Group

Phase 3 Active not recruiting
540 enrolled
CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡